Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIR Inhaled Insulin vs Insulin Glargine in Insulin-Naive Type 2 Diabetes
NCT00437112Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2007
- Primary completion
- May 2008
- Countries
- 5
01
Overview
A Phase 3 trial of AIR Inhaled Insulin in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Feb 2007; status: completed.
02
Drugs
AIR Inhaled Insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00437112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00437112.